Physician profile
Elecia E Kim
NPI 1871851220
$2,094.91
in general payments reported to CMS, 2019-2025
21 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $53.70 · 2021: $361 · 2022: $449 · 2023: $271 · 2024: $322 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $730.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $271.79 | 2019-2023 | Shingrix, Bexsero, Arexvy |
| Amarin Pharma, INC. | $256.23 | 2020-2022 | |
| Astellas Pharma US INC | $170.26 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $137.97 | 2024-2025 | Airsupra |
| Merck Sharp & Dohme LLC | $83.66 | 2019-2021 | |
| Abbvie INC. | $77.71 | 2021-2022 | |
| Pfizer INC. | $57.04 | 2019-2024 | |
| Amgen INC. | $52.26 | 2021-2025 | Evenity |
| Boston Scientific Corporation | $43.12 | 2025 | Apollo Esg System |
| Abbott Laboratories | $37.88 | 2019-2023 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $34.41 | 2022 | |
| Lilly USA, LLC | $24.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.99 | 2019 | |
| Exact Sciences Corporation | $17.01 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.64 | 2023 | Livalo, Seglentis |
| E.R. Squibb & Sons, L.L.C. | $13.87 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.79 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.57 | 2021 | |
| Allergan, INC. | $12.49 | 2020 | |
| Vanda Pharmaceuticals INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elecia Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.